Additional file 1 of Sodium-glucose cotransporter 2 inhibitors, inflammation, and heart failure: a two-sample Mendelian randomization study

Additional file1: Table S1. Detailed information for genome-wide association studies involved in the present Mendelian randomization study. Table S2. Instrumental variables for SGLT2 inhibition. Table S3. Mendelian Randomization analysis on the causal effect between SGLT-2 inhibitor and inflammatory biomarkers. Table S4. Mendelian Randomization analysis on the causal effect between inflammatory biomarkers and heart failure. Table S5. Ranking of models for heart failure according to their posterior probability after exclusion of outlying and influential variants in MR-BMA analysis. Table S6. Characteristics of participating studies.